posted on 2011-11-04, 00:00authored byDessing M.C., Pulskens W.P., Teske G.J., Butter L.M., van der Poll T., Yang H., Tracey K.J., Nawroth P.P., Bierhaus A., Florquin S.
The receptor for advanced glycation end products (RAGE) mediates a variety of inflammatory responses in renal diseases, but its role in renal ischemia/reperfusion (I/R) injury is unknown. We showed that during renal I/R, RAGE ligands HMGB1 and S100B are expressed. However, RAGE deficiency does not affect renal injury and function upon I/R-induced injury.